Estadísticas de Erythropoietin Treatment in Chronic Renal Failure Anaemia-Biosimilar Option in the Rational Use of Medicine Process in Order to Reduced Public Health Economic Burden
Visitas totales
| views | |
|---|---|
| Erythropoietin Treatment in Chronic Renal Failure Anaemia-Biosimilar Option in the Rational Use of Medicine Process in Order to Reduced Public Health Economic Burden | 42 |
Visitas totales por mes
| views | |
|---|---|
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
| diciembre 2024 | 0 |
| enero 2025 | 0 |
Visitas de archivo
| views | |
|---|---|
| Marin - Erythropoietin Treatment in Chronic Renal Failure Anaemia-Biosimilar Option in the Rational Use of Medicine Process in Order to Reduced Public Health Economic Burden.pdf-PDFA.pdf | 116 |
| ERYTHROPOIETIN TREATMENT.pdf | 7 |
Vistas principales por país
| views | |
|---|---|
| Estados Unidos | 5 |
| Argentina | 4 |
| Egipto | 4 |
| Australia | 3 |
| Suecia | 3 |
| Singapur | 3 |
| Venezuela | 1 |
Visitas principales por ciudad
| views | |
|---|---|
| Buenos Aires | 3 |
| Brisbane | 1 |
| Caracas | 1 |
| Damanhur | 1 |
| Denver | 1 |
| Des Moines | 1 |
| Giza | 1 |
| Houston | 1 |
| Inglewood | 1 |
| La Plata | 1 |
| Rozelle | 1 |
| Sohag | 1 |
| Sydney | 1 |
| Tala | 1 |